| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 8,700 | 4,350 | 4,350 |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| SLC STUDENT LN FLT 2032 | 1,457,199 | 1,476,363 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| 43,049 ANHEUSER BUSCH INBEV SA (BUDFF) | 4,791,302 | 2,603,407 |
| 477,303 SHARES OF FORMA THERAPEUTICS (FMTX) | 2,565,364 | 6,787,249 |
| ORIONIS BIOSCIENCES | 2,999,983 | 2,999,983 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| DE SHAW COMPOSITE INTL FUND | AT COST | 6,720,740 | 20,316,705 |
| DE SHAW OCULUS FUND | AT COST | 3,226,224 | 7,954,870 |
| DE SHAW VALENCE FUND | AT COST | 10,226,224 | 35,353,696 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| DISTRIBUTION RECEIVABLE - DE SHAW ALKALI INTL FUND II | 313,518 | 0 | 0 |
| Description | Amount |
|---|---|
| SECURITIES BASIS ADJUSTMENT | 4,104,945 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| MASS FILING FEE PAID | 70 | 0 | 0 | |
| SCHWAB - BANK CHARGES | 234 | 0 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| SCHWAB - FOREIGN TAX WITHHELD | 7,824 | 7,824 | 0 |